filmov
tv
Paracetamol, Shelcal, Pan D Among 53 Meds ‘Not Of Standard Quality’
Показать описание
#CDSCO #Medicines #DrugQualityAlert #PharmaIndustry #MedicineRecall #HealthcareSafety
More than 50 drugs, including Calcium and Vitamin D3 supplements, anti-diabetes pills, and high blood pressure medicines have failed quality tests by the drug regulator. In its latest monthly drug alert list, the Central Drugs Standards Control Organisation (CDSCO) declared 53 drugs as ‘Not of Standard Quality (NSQ) Alert’. NSQ alerts are generated from random monthly sampling conducted by state drug officers. As India Today’s Milan Sharma explains, Vitamin C and D3 tablets, Shelcal, Vitamin B Complex and Vitamin C softgels, Antiacid Pan-D, Paracetamol tablets IP 500 mg, anti-diabetic drug Glimepiride, high blood pressure drug Telmisartan, and many more are among the 53 top-selling drugs that failed the quality check by the drug regulator. These medicines are manufactured by Hetero Drugs, Alkem Laboratories, Torrent Pharma, Sun Pharma, Hindustan Antibiotics Limited (HAL), Karnataka Antibiotics & Pharmaceuticals Ltd, Meg Lifesciences, Pure & Cure Healthcare and several other companies. In August, the CDSCO banned over 156 fixed-dose drug combinations in the Indian market that are "likely to involve risk to humans". These medicines included popular fever drugs, painkillers and allergy tablets.
#FailedDrugTests #NSQAlert #PharmaceuticalRegulation #DrugSafety #HealthAlert #DrugRegulation #PharmaAlert #MedicineQuality #HealthRisk #FailedMedicines #PharmaCompliance #DrugSafetyAlert #QualityControl #PatientSafety #HealthcareQuality
-----------------------
Thank You for watching! Do not forget to Like | Comment | Share
-----------------------
About the channel
Watch us for the best news and views on business, stock markets, crypto currencies, consumer technology, the world of real estate, bullion, automobiles, start-ups and unicorns and personal finance. Business Today TV will also bring you all you need to know about mutual funds, insurance, loans and pension plans among others.
Follow us at:
More than 50 drugs, including Calcium and Vitamin D3 supplements, anti-diabetes pills, and high blood pressure medicines have failed quality tests by the drug regulator. In its latest monthly drug alert list, the Central Drugs Standards Control Organisation (CDSCO) declared 53 drugs as ‘Not of Standard Quality (NSQ) Alert’. NSQ alerts are generated from random monthly sampling conducted by state drug officers. As India Today’s Milan Sharma explains, Vitamin C and D3 tablets, Shelcal, Vitamin B Complex and Vitamin C softgels, Antiacid Pan-D, Paracetamol tablets IP 500 mg, anti-diabetic drug Glimepiride, high blood pressure drug Telmisartan, and many more are among the 53 top-selling drugs that failed the quality check by the drug regulator. These medicines are manufactured by Hetero Drugs, Alkem Laboratories, Torrent Pharma, Sun Pharma, Hindustan Antibiotics Limited (HAL), Karnataka Antibiotics & Pharmaceuticals Ltd, Meg Lifesciences, Pure & Cure Healthcare and several other companies. In August, the CDSCO banned over 156 fixed-dose drug combinations in the Indian market that are "likely to involve risk to humans". These medicines included popular fever drugs, painkillers and allergy tablets.
#FailedDrugTests #NSQAlert #PharmaceuticalRegulation #DrugSafety #HealthAlert #DrugRegulation #PharmaAlert #MedicineQuality #HealthRisk #FailedMedicines #PharmaCompliance #DrugSafetyAlert #QualityControl #PatientSafety #HealthcareQuality
-----------------------
Thank You for watching! Do not forget to Like | Comment | Share
-----------------------
About the channel
Watch us for the best news and views on business, stock markets, crypto currencies, consumer technology, the world of real estate, bullion, automobiles, start-ups and unicorns and personal finance. Business Today TV will also bring you all you need to know about mutual funds, insurance, loans and pension plans among others.
Follow us at:
Комментарии